Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for mixed phenotype acute leukemia with t(v;11q23.3).
2 publications have been identified in PubMed for mixed phenotype acute leukemia with t(v;11q23.3). Research spans Review / Meta-Analysis (50%) and Clinical Trial Publication (50%).
Hu Z (2024). [PMID: 39736728](https://pubmed.ncbi.nlm.nih.gov/39736728/). *BMC medicine*. [Clinical Trial Publication]
Park HS (2024). [PMID: 38616211](https://pubmed.ncbi.nlm.nih.gov/38616211/). *Blood research*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:11 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
AI-curated news mentioning mixed phenotype acute leukemia with t(v;11q23.3)
Updated Sep 2, 2026
A multi-center case series investigates clinical outcomes and molecular features of CEBPA-mutated mixed phenotype acute leukemia (MPAL). The findings contribute to understanding the disease's biology and potential treatment strategies.
A rare case report details mixed phenotype acute leukemia presenting symptoms similar to adult-onset Still's disease in a pregnant female. This case highlights the diagnostic challenges and the need for awareness of overlapping symptoms in rare diseases.